Bioprocessing - Upstream & Downstream

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

It’s time to celebrate The Medicine Maker annual Innovation Awards! Here, we showcase the top technologies released during 2021.

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

Edd Stone of The Technology Partnership outlines current challenges in the cell and gene field - and what we can do about them.

Applying advanced technologies to bioprocessing operations will only help improve success rates.